Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Bonagens
WARNING LETTER
•Bonagens•January 12, 2021

Bonagens – FDA Warning Letter, Jan 12, 2021

Record Details

The FDA reviewed Bonagens Inc.'s website, bonagensinc.com, in July 2020 and determined that products such as "Anti-Aging Supports," "Cholesterol & Diabetes Control," "Gout Control," "Hypertension Control," "Liver Supports," "Lungs Supports," "Vita-V for Men," and "Weight Lost" are marketed with claims establishing them as drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. 321(g)(1)(B)]. These claims indicate the products are intended for the cure, mitigation, treatment, or prevention of disease.

Specific examples of drug claims include "alleviate the effects of menopausal syndrome" for "Anti-Aging Supports," "significant decrease in fasting blood glucose" for "Cholesterol & Diabetes Control," and "reduce the uric acid" for "Gout Control."

These products are considered "new drugs" under section 201(p) of the Act [21 U.S.C. 321(p)] because they are not generally recognized as safe and effective for their intended uses. Introducing or delivering new drugs into interstate commerce without prior FDA approval violates sections 301(d) and 505(a) of the Act [21 U.S.C. 331(

Company
Bonagens
Inspection date
January 12, 2021
Product type
Food
Office
Division of Human and Animal Food Operations - East III
Person
  • Ingrid A. Zambrana
View Company Profile

ID · 5f2e1df3-ad6f-4f71-91f2-7160f827aea1

Violation Codes8
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Bonagens
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.